The FDA approved lurbinectedin (Zepzelca) plus either atezolizumab (Tecentriq) or atezolizumab and hyaluronidase (Tecentriq ...

By Dennis Thompson HealthDay ReporterTHURSDAY, Oct. 2, 2025 (HealthDay News) — A genetic risk score can help predict which ...

Hodgkin lymphoma and other malignancies that express the CD30 protein have been the scourge of oncologists for decades. For ...

When cancer cells are physically squeezed, they mount an instant, high-energy defense by rushing mitochondria to the cell ...

Obesity and poor diet choices can increase colon cancer risk, but sustained, healthy weight loss can offer lasting protection ...

Triple negative breast cancer (TNBC) is one of the most aggressive and hardest forms of breast cancer to treat, but a new ...

Cancer cells transfer mitochondria through nanotubes to healthy neighboring cells, turning them into tumor-supporting accomplices, a new study shows.

Ohio State researchers have discovered that exhausted T cells collapse under the weight of misfolded proteins, activating a ...

Japanese scientists successfully eliminated cancer tumors using live bacteria, a new therapy that acts independently of the ...

It is largely due to advances in treatment that there are now more than 220,000 people in Ireland living with or after cancer ...

Cancer cells are pretty bold and clever—they hijack cellular survival and healing processes in order to fuel their growth, ...

A protein notorious for its role in Alzheimer’s disease may hold the key to supercharging the aging immune system, according ...